Literature DB >> 23776060

Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry.

Lenka Hernychova1, Petr Man, Chandra Verma, Jude Nicholson, Carrie-Anne Sharma, Eva Ruckova, Jin Yuan Teo, Kathryn Ball, Borek Vojtesek, Ted R Hupp.   

Abstract

MDM2 is a multidomain protein that functions as an E3 ubiquitin ligase, transcription repressor, mRNA-binding protein, translation factor, and molecular chaperone. The small molecule Nutlin-3 has been engineered to bind to the N-terminal hydrophobic pocket domain of MDM2. This binding of Nutlin-3 has two consequences: (i) antagonistic effects through competitive disruption of the MDM2-p53 complex and (ii) agonist effects that allosterically stabilize MDM2 protein-protein interactions that increase p53 ubiquitination as well as nucleophosmin deoligomerization. We present a methodology using a hydrogen/deuterium (H/D) exchange platform that measures Nutlin-3 binding to the N-terminal domain of MDM2 (MDM2(1-126)) in order to begin to develop dynamic assays that evaluate MDM2 allostery. In order to localize the regions in MDM2 being suppressed by Nutlin-3, MDM2 was incubated with the ligand and H/D amide exchange was measured after pepsin digestion. One dynamic segment containing amino acids 55-60 exhibited slower deuterium exchange after Nutlin-3 binding, reflecting ligand binding within the hydrophobic pocket. However, another dominant suppression of H/D exchange was observed in a motif from amino acids 103-107 that reflects surface hydrophobic residues surrounding the hydrophobic pocket of MDM2. In order to explore the consequences of this latter Nutlin-3 interaction site on MDM2, the Y104G and L107G mutant series was constructed. The MDM2(Y104G) and MDM2(L107G) mutants were fully active in p53 binding. However, the authentic p53-derived peptide:MDM2(Y104G) complex exhibited partial resistance to Nutlin-3 inhibition, while the p53-mimetic 12.1 peptide:MDM2(Y104G) complex retained normal Nutlin-3 responsiveness. These data reveal the existence of a second functional Nutlin-3-binding site in a surface hydrophobic patch of MDM2, flanking the hydrophobic pocket. This reveals two modes of peptide binding by MDM2 and highlights the utility of H/D exchange as an assay for measuring allosteric effects in MDM2.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Allostery; Biomedicine; Cancer; Deuterium exchange; MDM2; p53

Mesh:

Substances:

Year:  2013        PMID: 23776060     DOI: 10.1002/pmic.201300029

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

Review 1.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

2.  p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.

Authors:  Ixaura Medina-Medina; Mayra Martínez-Sánchez; Jesús Hernández-Monge; Robin Fahraeus; Petr Muller; Vanesa Olivares-Illana
Journal:  Protein Sci       Date:  2018-03-25       Impact factor: 6.725

3.  Hydrogen-Deuterium Exchange and Hydroxyl Radical Footprinting for Mapping Hydrophobic Interactions of Human Bromodomain with a Small Molecule Inhibitor.

Authors:  Ke Sherry Li; Elizabeth T Schaper Bergman; Brett R Beno; Richard Y-C Huang; Ekaterina Deyanova; Guodong Chen; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2019-11-12       Impact factor: 3.109

4.  Discovery of a novel ligand that modulates the protein-protein interactions of the AAA+ superfamily oncoprotein reptin.

Authors:  Alan R Healy; Douglas R Houston; Lucy Remnant; Anne-Sophie Huart; Veronika Brychtova; Magda M Maslon; Olivia Meers; Petr Muller; Adam Krejci; Elizabeth A Blackburn; Borek Vojtesek; Lenka Hernychova; Malcolm D Walkinshaw; Nicholas J Westwood; Ted R Hupp
Journal:  Chem Sci       Date:  2015-03-20       Impact factor: 9.825

Review 5.  Drugging the p53 pathway: understanding the route to clinical efficacy.

Authors:  Kian Hoe Khoo; Khoo Kian Hoe; Chandra S Verma; David P Lane
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

Review 6.  Applications of hydrogen/deuterium exchange MS from 2012 to 2014.

Authors:  Gregory F Pirrone; Roxana E Iacob; John R Engen
Journal:  Anal Chem       Date:  2014-11-14       Impact factor: 6.986

7.  Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations.

Authors:  Shilpa Yadahalli; Jianguo Li; David P Lane; Shachi Gosavi; Chandra S Verma
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

8.  Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design.

Authors:  Yaw Sing Tan; Judith Reeks; Christopher J Brown; Dawn Thean; Fernando Jose Ferrer Gago; Tsz Ying Yuen; Eunice Tze Leng Goh; Xue Er Cheryl Lee; Claire E Jennings; Thomas L Joseph; Rajamani Lakshminarayanan; David P Lane; Martin E M Noble; Chandra S Verma
Journal:  J Phys Chem Lett       Date:  2016-08-22       Impact factor: 6.475

9.  Inhibition of nutlin-resistant HDM2 mutants by stapled peptides.

Authors:  Siau Jia Wei; Thomas Joseph; Sharon Chee; Ling Li; Larisa Yurlova; Kourosh Zolghadr; Christopher Brown; David Lane; Chandra Verma; Farid Ghadessy
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

10.  The Sequence-specific Peptide-binding Activity of the Protein Sulfide Isomerase AGR2 Directs Its Stable Binding to the Oncogenic Receptor EpCAM.

Authors:  M Aiman Mohtar; Lenka Hernychova; J Robert O'Neill; Melanie L Lawrence; Euan Murray; Borek Vojtesek; Ted R Hupp
Journal:  Mol Cell Proteomics       Date:  2018-01-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.